Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shiraki

Showing results (31-40 of 222) with videos related to

Pageof 23
Sort By:
Biochemical Pharmacology|October 19, 1993
Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activityY Koshihara, K Hoshi, M Shiraki
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1987
[Shortcomings of electronic endoscopy. e. The lower digestive tract]M Shiraki, N Ohsaka, S Ohshiba
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 25, 2012
Effects of a single injection of teriparatide on bone turnover markers in postmenopausal womenM Shiraki, T Sugimoto, T Nakamura
Journal of Bacteriology|January 1, 1997
Purification of an extracellular D-(-)-3-hydroxybutyrate oligomer hydrolase from Pseudomonas sp. strain A1 and cloning and sequencing of its geneK Zhang, M Shiraki, T Saito
Nihon Naibunpi Gakkai Zasshi|November 20, 1989
[The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study]M Shiraki, H Ito, H Orimo
Endocrine Journal|January 9, 1999
Bone and calcium metabolism in Werner's syndromeM Shiraki, C Aoki, M Goto
Clinical and Experimental Immunology|January 1, 1985
Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 miceM Fujiwara, A Kariyone, M Shiraki
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 20, 2011
Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosisT Nakamura, T Matsumoto, T Sugimoto, et al.
Horumon to Rinsho. Clinical Endocrinology|October 1, 1983
[Treatment of postmenopausal osteoporosis with 1,25 dihydroxycholecalciferol]M Shiraki, M Akiguchi, H Ifuji, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1993
Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitroK Hara, Y Akiyama, T Tajima, et al.
Pageof 23

Showing results (31-40 of 222) with videos related to

Sort By:
Pageof 23
Biochemical Pharmacology|October 19, 1993
Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activityY Koshihara, K Hoshi, M Shiraki
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 1, 1987
[Shortcomings of electronic endoscopy. e. The lower digestive tract]M Shiraki, N Ohsaka, S Ohshiba
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 25, 2012
Effects of a single injection of teriparatide on bone turnover markers in postmenopausal womenM Shiraki, T Sugimoto, T Nakamura
Journal of Bacteriology|January 1, 1997
Purification of an extracellular D-(-)-3-hydroxybutyrate oligomer hydrolase from Pseudomonas sp. strain A1 and cloning and sequencing of its geneK Zhang, M Shiraki, T Saito
Nihon Naibunpi Gakkai Zasshi|November 20, 1989
[The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study]M Shiraki, H Ito, H Orimo
Endocrine Journal|January 9, 1999
Bone and calcium metabolism in Werner's syndromeM Shiraki, C Aoki, M Goto
Clinical and Experimental Immunology|January 1, 1985
Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 miceM Fujiwara, A Kariyone, M Shiraki
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 20, 2011
Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosisT Nakamura, T Matsumoto, T Sugimoto, et al.
Horumon to Rinsho. Clinical Endocrinology|October 1, 1983
[Treatment of postmenopausal osteoporosis with 1,25 dihydroxycholecalciferol]M Shiraki, M Akiguchi, H Ifuji, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1993
Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitroK Hara, Y Akiyama, T Tajima, et al.
Pageof 23